Pharma & APIs
Redundancy· Pharma & APIs · Link

Seqens, Roussillon paracetamol unit

Roussillon, France45.37°N 4.82°E
computed criticality29/100
reading
A new paracetamol unit under construction at the Roussillon platform, a continuous process, with start-up announced for 2026 and commercialization targeted for 2027. Announced capacity of about 15,000 tonnes per year.
2025
Fault line

No base paracetamol production had remained in France since the closure of the Rhodia workshop in 2008. The project, backed by France 2030, will only cover needs after qualification, with Europe remaining dependent on China and India in the meantime.

Actors
Seqens
Opella
UPSA
France 2030
Feeds 2
Delpharm, contract manufacturer (Reims)Pharma & APIsSeqens, Villeneuve-la-Garenne sitePharma & APIs
Sources